Market Tracker

03/22 5:16pm ET

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

3.06
Delayed Data
As of Mar 22
 -0.10 / -3.16%
Today’s Change
0.84
Today|||52-Week Range
6.63
+126.67%
Year-to-Date

Today’s Trading

Previous close3.16
Today’s open3.16
Day’s range3.01 - 3.21
Volume553,633
Average volume (3 months)1,048,434
Market cap$159.3M
Dividend yield--
Data as of 4:00pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)+76.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+101.00%
Revenue growth (last year)-82.83%
P/E ratioNM
Price/Sales3.58
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
COCPCocrystal Pharma Inc+0.01+6.82%
NYMXNymox Pharmaceutical...-0.01-0.31%
OCXOncoCyte Corp+0.08+1.49%
IMDZImmune Design Corp-0.05-0.76%
Data as of 4:00pm ET, 03/22/2017

Financials

Last reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$18.7M
Annual profit (last year)-$30.1M
Net profit margin-160.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Adelene Q. Perkins
President, EVP, Chief Financial &
Business Officer
Lawrence E. Bloch
Corporate headquarters
Cambridge, Massachusetts

Forecasts